platforms and services can provide direct benefits to both the healthcare industries
and consumers using them.
Our Research conducted a targeted industry survey of experts and key opinion
leaders in the AI field to gather insight and opinions on the current trends and future
commercial prospects of the use of AI within the healthcare and pharmaceutical
sectors. The survey explored a wide range of strategic topics in the field, including
key market drivers and restraints, and the most common areas where the AI
technologies are being applied within the pharmaceutical pipeline development
chain, prospects for future investments in AI, important factors to consider when
implementing AI in industry, and other important areas for current and future
investors in AI.
The report also provides an analysis of the main challenges surrounding the adoption
of AI technologies within the healthcare and pharmaceutical industries. AI
developers and investors in the market will still need to address significant barriers
to achieve higher adoption rates in the market. Mitigating risks and concerns
regarding data security and privacy will be crucial.
Other important restraints identified in this report include the currently unclear
regulatory and legal frameworks surrounding AI, and the shortage of skilled IT
professional in the healthcare industry. Despite the aforementioned barriers to the
further expansion of the AI market, growing investment in AI and digital
pharmaceutical developments represent encouraging trends.
Scope
- How prevalent is the usage of AI technologies within the healthcare and
pharmaceutical sectors and how will this change in the coming years?
- What are the most important drivers and restraints of AI adoption within
healthcare and pharmaceuticals?
- What are the key stakeholders in the funding and provision of AI technologies
within healthcare and pharmaceuticals?
- How will different sectors, such as clinical trials, diagnostics and epidemiological
forecasting be impacted by AI technologies?
Reasons to buy
- Develop a comprehensive understanding of AI technologies and their applications
within the healthcare and pharmaceutical sectors
- Gain insight into the key players within the industry, including multi-national
technology firms and AI start-up firms, with case studies and company profiles
- Analyze trends within the AI strategic consolidations landscape
- Gain insights from industry experts on the current status and future prospects for
AI within healthcare and pharmaceuticals (GBI Research’s survey comprises
responses from 105 organizations)